You are here

Article info

Article menu
Genotype-phenotype correlations
Original article
Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome
Free

Authors

  1. Correspondence to Dr Michelle Olsen, Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, 1918 University Boulevard, MCLM 958, Birmingham, AL 35294, USA; molsen{at}uab.edu; Dr Jeffrey L Neul, Jan and Dan Duncan Neurological Research Institute, 1250 Moursund Street, Suite 1250, Houston, TX, 77030, USA; jneul@bcm.edu
View Full Text

Citation

Cuddapah VA, Pillai RB, Shekar KV, et al
Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome
Journal of Medical Genetics 2014;51:152-158.

Publication history

  • Received October 12, 2013
  • Accepted December 4, 2013
  • First published January 7, 2014.
Online issue publication 
April 27, 2016

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions